News and blogs

Mandatory HIV testing is a ‘knee-jerk and untenable reaction’, and it ultimately does not get more people testing for HIV.

A study of gay men in Malawi reveals very low levels of HIV testing and treatment access nationwide – with distinct geographic disparities in HIV prevalence that need to be taken into consideration and addressed.

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.

There is a high appetite for increased access to pre-exposure prophylaxis (PrEP) among gay app users in Switzerland, according to research looking into the need for a national PrEP programme.

Reducing the number of age-disparate relationships in east and southern Africa could help to decrease HIV infection rates among young women in the region.

There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

Women’s views on voluntary male medical circumcision form an important part of the delivery and mass roll-out of this HIV prevention strategy.

A number of southern African countries are making good progress towards the 90-90-90 Fast-Track Targets, but efforts to reach younger populations need to be redoubled.

This World AIDS Day we've chosen ten pivotal events from the history of the HIV epidemic you should know about.

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

We count down the top five things that everybody should know about HIV - from AIDS, to testing, to symptoms, to treatment.

Viral load testing could become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.

Concerns have been raised about the shortage of antiretroviral drugs available for people living with HIV in Venezuela, which is in the midst of a mounting health crisis.

Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.